Skip to main content
. 2020 Dec 17;15:349. doi: 10.1186/s13023-020-01637-9

Table 2.

Clinical characteristics of fourteen patients with GD-T1 with abnormality of saccadic velocity in three or more measures

Age Age Dx Age at ERT Genotype Spleen Gaucher related Co-morbidities Number of velocity measures abnormal Direction of abnormality Clinical saccade abnormality
53 5 32 R463C/RecNcil S Liver disease 4 Left & right Y
49 19 37 R463C/RecNcil S 6 All Y
55 47 47 R262G/RecNcil Abnormal neurology 4 Left, right, down Y
48 4 25 R463C/IVS2+1 S Liver disease & Lung disease 6 Left, right, down Y
77 56 57 R463C/L444P Lung disease 6 Left, right, up Y
15 8 8 R463C/R257Q 8 All
70 6 54 R463C/G377R S Lung disease 5 All Y
64 6 46 R463C/RecNcil S Cognitive Impairment 6 Left, right, down Y
18 3 3 R463C/N462K 4 Left & down
73 48 56 R463C/L444P S 6 All Y
31 5 6 R463C/L444P Liver disease & subtle ataxia 8 All Y
43 2 27 R463C/L444P S 8 All
16 3 3 R463C/RecNcil 3 Right & down
12 11mo 1 H311R/R359Q Liver disease; lung disease & lymphadenopathy 4 Left & right Y

Dx: Diagnosis; Age given in years; Genotype: Traditional GBA1 variant nomenclature used; R463C (p.Arg502Cys); RecNcil (recombinant consisting of multiple pseudo-gene derived point mutations); L444P (p.Leu483Pro); IVS2+1 (Splice site variant c.115+1G > A); G377R (p.Gly416Arg); R262G (p.Arg301Gly); R257Q (p.Arg296Gln); N462K (p.Asn501Lys)

S, splenectomised; Y, yes/present

*Genotype documented but not confirmed